Document Detail


Hyperpolarized (13) C-labelled anhydrides as DNP precursors of metabolic MRI agents.
MedLine Citation:
PMID:  22821881     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The extraordinary enhancement of the nuclear magnetic resonance (NMR) signal that can be obtained by dynamic nuclear polarization (DNP) techniques is prompting new avenues of research based on the in vivo detection of metabolic abnormalities associated with the onset and progression of human diseases. (13) C-labelled short-chain fatty acids appear to be interesting candidates for this novel class of metabolic-active contrast agents (MCAs), as they have been shown to report on metabolic differences between healthy and ischaemic tissues in mice. In spite of their promising biological efficacy, the formulations of short-chain fatty acids that fulfil the many technical constraints of the DNP procedure, as it is today, may limit their clinical potential. New solutions have been sought to circumvent technology-related challenges and facilitate clinical translation of these molecules. In particular, it has been shown that, by using symmetric anhydrides as chemical precursors for short-chain fatty acids, no glass-forming additives are needed in the DNP formulations. Furthermore, novel esterified trityl radicals and lipophilic gadolinium complexes allow easy removal of the polarization-promoting additives at the end of the DNP process. By applying the three concepts reported, we have succeeded in preparing aqueous formulations of short-chain fatty acids for pharmaceutical use that have favourable properties compared with those obtained from current procedures. The use of organic derivatives as chemical precursors of the MCA of interest appears to be a generally valid concept, not restricted to symmetric anhydrides of fatty acids, which can markedly improve the clinical potential of other (13) C-labelled compounds. Copyright © 2012 John Wiley & Sons, Ltd.
Authors:
Sonia Colombo Serra; Magnus Karlsson; Giovanni Battista Giovenzana; Camilla Cavallotti; Fabio Tedoldi; Silvio Aime
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Contrast media & molecular imaging     Volume:  7     ISSN:  1555-4317     ISO Abbreviation:  Contrast Media Mol Imaging     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-07-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101286760     Medline TA:  Contrast Media Mol Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  469-77     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Affiliation:
Centro Ricerche Bracco, Bracco Imaging Spa, Via Ribes 5, 10010, Colleretto Giacosa, (TO), Italy; Dipartimento di Fisica Sperimentale, Università degli Studi di Torino, Via Giuria 1, 10125, Torino, (TO), Italy. sonia.colombo@bracco.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) ...
Next Document:  A smart (19) F and (1) H MRI probe with self-immolative linker as a versatile tool for detection of ...